Care
HIMSS22
In-person conference drives energy and partnerships for growth, say representatives from exhibitors DeliverHealth, Consensus and Arcadia.
The mental health company will use Curebase's decentralized clinical trial platform to study its treatment program's efficacy.
A review of studies published in npj Digital Medicine found digital and face-to-face CBT show similar effectiveness for treating depression.
Smart stethoscope company Eko received a $2.7 million grant from the National Institutes of Health, and Halo raised $2.6 million for its research and development collaboration tool.
HIMSS22
Speaking with companies who showcase their latest transformative products in the healthcare industry.
The company announced a $200 million Series C round in January.
The startup will use the seed funding to launch services in California, Texas and Washington this year.
Pivot Point Consulting SVP of Strategy Laura Kreofsky discusses the shift toward healthcare consumerism and how retailers moving into the healthcare space could improve health equity for underserved populations.
The Rhythm Evaluation for AntiCoagulaTion (REACT-AF) trial will study a "pill-in-pocket" method of stroke prevention for patients with atrial fibrillation. Some participants will monitor for AFib using an Apple Watch and take blood thinners as needed, instead of using the drug continuously.
Hopes for a Senate telehealth bill passage, public health infrastructure modernization and the European Health Data Space are just a few of the priorities on the HIMSS agenda, says Tom Leary, the group's senior VP and head of government relations.